Tibetan medicinal preparation for treating essential hypertension and preparation method thereof
A technology of essential hypertension and Tibetan medicine, which is applied in the direction of medical formula, medical preparations containing active ingredients, drug delivery, etc., and can solve problems such as pressure rise, incomplete discharge, and pipeline blockage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
experiment example 1
[0091] [Experimental example 1] the influence of single administration of the medicine of the present invention on SHR tail artery blood pressure and heart rate
[0092] 1. Effect of single administration on SHR tail artery systolic blood pressure (SBP)
[0093] Model group systolic blood pressure is significantly higher than WKY group (P<0.01); Single gavage medicine of the present invention, medicine 1-12 group of the present invention all has the effect of obviously reducing tail artery systolic pressure in administration 3h, 6h, 12h, and Compared with the model group, there was a significant difference (P<0.05~0.01); the captopril group could significantly reduce the systolic pressure of the tail artery at 1h, 6h, and 12h after administration, and there was a significant difference compared with the model group (P<0.05~0.01). 0.01). The results are shown in Table 2.
[0094] Table 2 The influence of single administration of medicine of the present invention on SHR tail a...
experiment example 2
[0121] [Experimental Example 2] Effects of continuous administration of the medicine of the present invention for 4 weeks on SHR tail artery blood pressure and heart rate
[0122] 1. Effect of continuous administration for 4 weeks on SHR tail artery systolic blood pressure (SBP)
[0123] The systolic blood pressure of the model group was significantly higher than that of the WKY group (P<0.01); continuous administration of the medicine of the present invention, the medicine of the present invention 1-12 groups all had the effect of significantly reducing the systolic blood pressure of the tail artery in the first week of administration, compared with the model group There was a significant difference (P<0.05~0.01); the captopril group began to lower blood pressure at the first week of administration, and the antihypertensive effect continued until 4 weeks after administration, which was significantly different from the model group (P<0.01) . The results are shown in Table 6. ...
Embodiment 1
[0152] [Example 1] Preparation of Tibetan medicine slow-release preparation of the present invention
[0153] Caragana 100g, Pashaga 150g, Honglian 50g, Corydalis 150g, Songsheng et al. ointment 50g, Emlical seed 180g;
[0154] Remove impurities, wash and mix the medicinal materials such as Tibetan Caragana, Baxiaga, Honglian, Corydalis, Songsheng and other medicinal materials respectively, and reflux extraction with 65% ethanol 10 times the weight of the raw material medicine for 3 times, each time Extract for 2 hours, collect and combine the extracts, filter, concentrate the extracts into a concentrated solution with a relative density of 1.15; add conventional auxiliary materials, and make the slow-release preparation of Tibetan medicine of the present invention according to conventional processes.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com